Status:
COMPLETED
ION US Post-Approval Study
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Atherosclerosis
Coronary Artery Disease
Eligibility:
All Genders
18-110 years
Brief Summary
The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.
Detailed Description
The ION™ stent is the third-generation Boston Scientific (BSC) paclitaxel-eluting coronary stent. It is designed for improved performance specific to deliverability and radio-opacity while maintaining...
Eligibility Criteria
Inclusion
- Consented subjects receiving one or more ION(TM)Coronary Stents
Exclusion
- Subjects not clinically indicated to receive an ION (TM)Coronary Stent
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
1120 Patients enrolled
Trial Details
Trial ID
NCT01422889
Start Date
September 1 2011
End Date
February 1 2015
Last Update
February 4 2016
Active Locations (40)
Enter a location and click search to find clinical trials sorted by distance.
1
NEA Baptist Memorial Hospital
Jonesboro, Arkansas, United States, 72401
2
St. Bernard's Medical Center
Jonesboro, Arkansas, United States, 72401
3
Bakersfield Memorial Hospital
Bakersfield, California, United States, 93301
4
Alvarado Hospital
San Diego, California, United States, 92121